Entrada Therapeutics, Inc. · NASDAQ:TRDA
Kush Parmar reported a 10.80% stake in Entrada Therapeutics, Inc. (Schedule 13D/A)
Event Nov 14, 2025 · Filed Nov 18, 2025
Kush Parmar reported a 10.80% stake in Entrada Therapeutics, Inc., 4,123,849 shares, with active intent on Nov 14, 2025. Filed Nov 18, 2025 (Schedule 13D/A).
- Stake
- 10.80%
- Shares
- 4,123,849
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| 5AM Ventures V, L.P. | 7.80% | 2,963,066 |
| 5AM Partners V, LLC | 7.80% | 2,963,066 |
| 5AM Opportunities I, L.P. | 2.90% | 1,093,313 |
| 5AM Opportunities I (GP), LLC | 2.90% | 0 |
| Andrew J. Schwab | 10.60% | 4,056,379 |
| Kush Parmar | 10.80% | 4,123,849 |
| Scott M. Rocklage | 7.80% | 2,963,066 |
Source
Related
- Entrada Therapeutics, Inc.
- Parmar Kush
- Entrada Therapeutics, Inc. shareholders
- Schedule 13D/A · Ansbert Gadicke · Sep 10, 2026
- Form 4 · MPM BioVentures 2018 GP LLC · Sep 9, 2026
- Form 4 · Mpm Bioventures 2018 (B), L.P. · Sep 9, 2026
- Form 4 · MPM BioVentures 2018 LLC · Sep 3, 2026
- Form 4 · MPM BioVentures 2014 GP LLC · Sep 3, 2026